Feedback Plc · LSE:FDBK
Feedback — FY2022 Earnings Presentation
27 slides from Feedback's earnings presentation, Sep 20, 2022
Slide 1: Investor presentation: Results for the year ended 31 May 2022
Investor presentation Results for the year ended 31 May 2022 20 September 2022
Slide 2: Disclaimer
Disclaimer The contents of this presentation have not been approved by an authorised person within the meaning of Section 21 of the Financial Services and Markets Act 2000 (as amended) ("FSMA"). Reliance on the contents of this presentation for the purpose of engaging in any investment activity may
Slide 3: Company overview
Company overview Leading specialist clinical communications platform, well-positioned to capitalise on digital transformation underway in 1 healthcare in the UK and internationally for both human and animal care Growing routes to market with Bleepa and CareLocker solutions delivering secure, complia
Slide 4: Operational highlights
Two Bleepa contract wins with NHS trusts worth an aggregate value of £0.20m First non-NHS contract win, with CVS Group Expansion of product suite and routes to market with launches of CareLocker and Operational BleepaBox highlights First international Bleepa deployment at Orissa, India, for remote T
Slide 5: Financial highlights
Financial highlights Highest ever reported revenue since becoming a medical imaging company in 2014 (all figures in £million) Revenue & Sales Adjusted EBITDA loss Revenue up 105% to £0.59m (2021: £0.29m) due to a full year of Bleepa revenues (initial commercialisation occurred in the final quarter o
Slide 6: Post-period highlights
Awarded £0.45m contract for a 12-month pilot extension of the Sussex ICS CDC development programme Post-period Named as a supplier on G-Cloud 13, the UK Government’s digital marketplace highlights Creation of the CareLocker app, giving patient's direct access to their clinical data First CareLocker
Slide 7: Product overview
r Product overview 1 FEEDBACKDIc
Slide 8: Product overview
Product overview f FEEDBACK
Slide 9: Connecting clinicians
Connecting clinicians A leading clinical imaging-based communication platform Safe Patient-specific structure: Removes misidentification risk Ensures information governance compliance Allows case discussion to link to core medical records Secure Zero footprint (no data stored locally on the access d
Slide 10: Our accreditations
Our accreditations CYBER ESSENTIALS DCB 0129 CERTIFIED PLUS HM Government G-Cloud alls » ASFEEDBACKOIC pg
Slide 11: Growth drivers
r Growth drivers 1 FEEDBACKDIc
Slide 12: NHS – contract awards
NHS – contract awards Acute trusts “With Bleepa you can see all the patient information remotely and don’t need to physically see the patient to deal with the referral” Contract Value: £102k/annum Ayman Kasir User base: 332 clinicians and growing Locum Registrar – Gastroenterology Number of specialt
Slide 13: NHS contract awards
NHS contract awards Community diagnostic centres • First phase development completed implementing Bleepa + CareLocker with Sussex Integrated Care System • Connects 3 GP practices with clinicians at 1 CDC and multi-disciplinary team in 1 hospital Contract Value: £450k/annum • First CDC site to delive
Slide 14: Community diagnostic centres (CDCs)
Community diagnostic centres (CDCs) NHS England’s ambition is to bring diagnostic investigations closer to patients to reduce the post- COVID elective care backlog and improve the patient journey. This will enable patients to have tests such as imaging, bloods and ECGs in high-street locations rathe
Slide 15: India – TB screening pilot program
India – TB screening pilot program Evangelical Hospital Khariar in Odisha Remote image upload using the Bleepa Box for AI processing and clinical referral • Processed over 500 cases, on average 30 cases/week • Partnered with AWS and Qure.ai BleepaBox video (YouTube): Delivering connected care for ha
Slide 16: India – CareLocker pilot
India – CareLocker pilot Sampurna Diagnostics pilot • CareLocker intended to be sold to Sampurna patients as a way of getting digital access to their images • Opportunity to assess the consumer market for CareLocker as a standalone product offering via a B2B2C route where imaging centres can on-sell
Slide 17: Veterinary – contract award
Veterinary – contract award CVS Equine division • Bleepa installed across 20 equine practices and 120 vets • Primary use case is remote image acquisition via Bleepa Box • 80% of images are taken in the field and need to be conveyed to a specialist in many cases • Secondary use case as a WhatsApp rep
Slide 18: Imaging Engineering LLC
Imaging Engineering LLC • Leveraging legacy technology to generate additional revenues • License to develop products based on Cadran technology for X-ray image capture enabling repair and update to existing rather than new equipment • Large domestic market within the US, approx. 2,000 sites reaching
Slide 19: Outlook
Outlook 1 Growing number of products, routes to markets and end customers 2 Significant opportunities enhanced by partnerships Strong focus on community diagnostic centres in the UK and India opportunities (TB screening and 3 CareLocker consumer app) 4 Proven value proposition of technology 19
Slide 20: Appendices
r Appendices 1 FEEDBACKDIc
Slide 21: 2022 – Consolidated income statement
2022 – Consolidated income statement 2022 2021 £ £ Revenue 588,576 287,415 Cost of sales (99,321) (25,024) Gross profit 489,255 262,391 Other operating expenses (3,002,489) (2,322,518) Operating loss (2,513,234) (2,060,127) Net finance income 2,012 281 Loss before taxation (2,511,222) (2,059,846) Ta
Slide 22: 2022 – Consolidated balance sheet
2022 – Consolidated balance sheet 2022 2021 £ £ Property, plant and equipment 8,367 13,773 Intangible assets 3,288,811 2,681,641 3,297,178 2,695,414 Trade and other receivables 308,293 138,042 Corporation tax receivable 392,351 767,120 Cash and cash equivalents 10,305,577 2,220,862 11,006,221 3,126,
Slide 23: 2022 – Consolidated cashflow statement
2022 – Consolidated cashflow statement 2022 2021 £ £ Cash flows from operating activities Loss before tax (2,511,222) (2,059,846) Adjustments for: Net finance income (2,012) (281) Depreciation and amortisation 552,931 48,755 Share based payment expense 68,265 162,615 Decrease/(increase) in trade rec
Slide 24: >£10bn opportunity estimated in core target markets
>£10bn opportunity estimated in core target markets Total addressable market analysis 1 2 3 4 5 6 7 8 9 North UK EU CareLocker America Private National TB ABDM(3) – NHS trusts NHS - CDCs veterinary veterinary consumer TOTAL veterinary hospitals screening health record sector sector app sector North
Slide 25: Feedback plc Board
Feedback plc Board Prof Rory Shaw, Non-executive Chairman: Dr Thomas Oakley, Chief Executive Officer Ex senior NHS executive, Medical Director since February 2019, previously Radiologist of Healthcare UK, Dept of International and Clinical Entrepreneur Fellow at NHS Trade, and consultant pulmonary p
Slide 26: Feedback Medical Ltd Leadership Team
Feedback Medical Ltd Leadership Team Dr Thomas Oakley, Chief Executive Officer since February 2019, previously Radiologist and Clinical Entrepreneur Fellow at NHS England. Anesh Patel, Chief Financial Mike Hayball, Chief Technology Stephen McAteer, Chief Operating Officer: Chartered Accountant Offic
Slide 27: Company history
Company history 2022 • Two Bleepa NHS contract wins • Pilot of UK’s first end-to-end symptom-based CDC pathway extended for 12 months • First international deployment of Bleepa for TB screening programme in Orissa • Bleepa gets 1st commercial contract at Royal Berkshire Hospitals NHS Foundation Trus